top of page
Developing innovative therapies that bring new hope to patients with dilated cardiomyopathy (DCM) — that is the mission of CardioGenix.
Shaping the Future of
Cardiomyopathy
Your contributions accelerate Dilated Cardiomyopathy (DCM) drug development. Donors receive regular research updates and efficacy evaluation reports of your desired drug using our DCM mouse model.
bottom of page